83 related articles for article (PubMed ID: 661303)
1. Multiple myeloma.
J Tenn Med Assoc; 1978 May; 71(5):357-61. PubMed ID: 661303
[No Abstract] [Full Text] [Related]
2. [Development of an anaplastic myeloma after 5-year evolution of IgA lambda multiple myeloma].
Soler J; Brunet S; Bordes R; Puig J
Sangre (Barc); 1987; 32(4):515-7. PubMed ID: 3116689
[No Abstract] [Full Text] [Related]
3. [Multiple myeloma--diagnosis, prognostic factors and treatment].
Kitani T
Rinsho Ketsueki; 1995 May; 36(5):471-9. PubMed ID: 7783353
[TBL] [Abstract][Full Text] [Related]
4. [Significance of prognostic indicators in multiple myeloma. I. Clinical, biochemical and radiographic indicators].
Scudla V; Wiedermann B; Wiedermann D; Indrák K
Vnitr Lek; 1984 Dec; 30(12):1145-55. PubMed ID: 6523766
[No Abstract] [Full Text] [Related]
5. Multiple Myeloma.
Levitt DZ
Am J Nurs; 1981 Jul; 81(7):1345. PubMed ID: 6910339
[No Abstract] [Full Text] [Related]
6. Multiple myeloma: new aspects of biology and treatment.
Ozaki S; Kosaka M
J Med Invest; 1998 Feb; 44(3-4):127-36. PubMed ID: 9597800
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-6 in multiple myeloma.
Bataille R; Klein B
Ann Med Interne (Paris); 1992; 143 Suppl 1():77-9. PubMed ID: 1300892
[No Abstract] [Full Text] [Related]
8. [A myeloma secreting immunoglobulin M (a report of 2 cases)].
Andreeva NE; Litvinenko AI; Iakovleva SV; Sokolova OM
Ter Arkh; 1992; 64(10):39-42. PubMed ID: 1485251
[No Abstract] [Full Text] [Related]
9. New insights into the biology and advances in the management of multiple myeloma.
Harousseau JL
Best Pract Res Clin Haematol; 2007 Dec; 20(4):569-70. PubMed ID: 18070706
[No Abstract] [Full Text] [Related]
10. Multiple myeloma. Preface.
Anderson KC
Hematol Oncol Clin North Am; 2007 Dec; 21(6):xiii-xiv. PubMed ID: 17996584
[No Abstract] [Full Text] [Related]
11. [Multiple myeloma].
Harousseau JL
Rev Prat; 1995 Jun; 45(12):1540-5. PubMed ID: 7660011
[No Abstract] [Full Text] [Related]
12. Multiple myeloma: recognition and management.
George ED; Sadovsky R
Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of novel therapeutic approaches for multiple myeloma.
Hideshima T; Anderson KC
Nat Rev Cancer; 2002 Dec; 2(12):927-37. PubMed ID: 12459731
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease.
Hungria VT; Latrilha MC; Rodrigues DG; Bydlowski SP; Chiattone CS; Maranhão RC
Cancer Chemother Pharmacol; 2004 Jan; 53(1):51-60. PubMed ID: 14574458
[TBL] [Abstract][Full Text] [Related]
15. [Multiple myeloma of the IgD class].
Madaliński K; Czechowska Z; Maj S; Nowoslawski A
Acta Haematol Pol; 1971; 2(1):75-81. PubMed ID: 5161847
[No Abstract] [Full Text] [Related]
16. [Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide].
Jurczyszyn A; Wolska-Smoleń T; Skotnicki AB
Przegl Lek; 2003; 60(8):542-7. PubMed ID: 14974349
[TBL] [Abstract][Full Text] [Related]
17. Biology and treatment of multiple myeloma.
Tosi P; Gamberi B; Giuliani N
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):81-6. PubMed ID: 16399590
[TBL] [Abstract][Full Text] [Related]
18. Iron in neoplastic cells of plasma cell myeloma.
Vidulich K; Hanks D; Etzell JE
Am J Hematol; 2006 Mar; 81(3):216-7. PubMed ID: 16493624
[No Abstract] [Full Text] [Related]
19. Multiple myeloma: primary bone tumor with systemic manifestations.
Bilsky MH; Azeem S
Neurosurg Clin N Am; 2008 Jan; 19(1):31-40. PubMed ID: 18156045
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of multiple myeloma.
Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
